BioCentury
ARTICLE | Clinical News

Doxil polyethylene glycol-conjugated liposomes containing doxorubicin data

May 22, 1995 7:00 AM UTC

LTIZ (Menlo Park, Calif.) announced that Phase III results in more than 200 patients have shown a significantly higher response rate, and that more patients completed the liposomal treatment than those receiving combination therapy with adriamycin, bleomycin, and vincristine. ...